Feasibility and Acceptability of PRISMA for Prisoners in Switzerland
Launched by UNIVERSITY OF ZURICH · May 6, 2024
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called PRISMA for Prisoners, aims to help improve the mental health of people in pretrial detention in Switzerland. Many detainees experience psychological distress, anxiety, depression, and thoughts of self-harm, and this program seeks to provide support through a special intervention based on effective therapy techniques. The trial will test how well the PRISMA program works and whether inmates find it helpful.
To participate, individuals must be at least 18 years old and entering one of the pretrial detention facilities in Zurich or Bern. They should also speak one of the nine languages in which PRISMA is offered. Unfortunately, those who are in acute distress or not interested in joining the study won’t be eligible. Participants can expect to engage in activities designed to improve their mental well-being and share their feedback on the program. This trial is an important step toward developing more effective mental health support for detainees.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Entering pretrial detention inmate in any of the 11 pretrial detention facilities in the Cantons of Zurich and Bern
- • aged ≥ 18 years
- Exclusion Criteria:
- • Not fluently speaking any of the nine languages in which PRISMA is offered: German, Albanian, Arabic, English, French, Italian, Romanian, Serbian/ Croatian, Spanish
- • Acute suicidality
- • Not interested in PRISMA and its randomized evaluation
About University Of Zurich
The University of Zurich, a leading institution in research and education, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust framework for conducting high-quality research, the university collaborates with multidisciplinary teams of experts to explore cutting-edge therapeutic approaches and interventions. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the utmost integrity, aiming to contribute valuable insights to the medical community and enhance health outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zürich, Zurich, Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported